OTC: RHHVF - Roche Holding AG

Yield per half year: -4.88%
Dividend yield: +3.88%
Sector: Healthcare

Roche Holding AG

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
16.36 31.52 -48.1% 19.22 -14.92%
P/S 3.11 3.23 -3.67%
P/BV 5.65 3.36 68.28%
P/FCF 20.45 21.22 -3.66%
Ev/Ebitda 11.98 9.93 20.61%
Ev/S 3.51 1.88 86.02%
Ev/FCF 18.51 19.91 -7.03%
E/P 0.0491 1.47 -96.66%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
32.97 24.35 35.39% 34.84 -5.37%
ROE 39.22 13.11 199.11%
ROA 12.71 6.09 108.54%
ROIC 0 15.56 -100%
ROS 19.02 12.44 52.94%
ROCE 0 14.35 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.25 6.21 -79.88% 1.25 -0.0278%
Nеt Debt/Ebitda 1.02 -5.72 -117.83%
Debt/Ratio 0.3229 0.213 51.58%
Debt/Equity 0.7522 12.49 -93.98%
Debt/Net Income 2.54 15.07 -83.14%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
9.7/10
3.88 1.76 120.27% 3.42 +13.44%
Number of years of dividend growth 4 1.21 230.23%
DSI 0.9286 0.7783 19.3%
Average dividend growth 3.61 -269.81 -101.34%
Average percentage for 5 years 3.42 2.8 22%
Average percentage for payments 66.11 246.95 -73.23%
Difference from average difference in sector 2.12

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-1.67 132.71 -101.26%
Growth impulse Ebitda in 5 years 10.38 100.7 -89.69%
Growth impulse Net Income in 5 years -14.81 116.53 -112.71%
Growth impulse FCF in 5 years -34.55 88.28 -139.14%
Growth impulse EPS in 5 years -8.13 217.84 -103.73%
IP Score
5.65/10

Similar companies

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription